Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer

Name: Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
Published: 2026
License: Public Domain

Shanghai Zhongshan Hospital · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

antigen celltherapy cholangiocarcinoma

biliary tract neoplasms, cholangiocarcinoma, intrahepatic, cholangiocarcinoma, extrahepatic, cholangiocarcinoma, perihilar, gallbladder cancer, adoptive t-cell therapy, antigen-specific t cells, cd160, autologous t cell therapy, biliary tract cancer, cholangiocarcinoma, aptc - antigen-presenting tumor cell

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 902360
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.